Zobrazeno 1 - 10
of 44
pro vyhledávání: '"G, Maschmeier"'
Autor:
T, Büchner, W, Hiddemann, B, Wörmann, M, Zühlsdorf, R, Rottmann, G, Innig, G, Maschmeier, W D, Ludwig, M C, Sauerland, A, Heinecke
Publikováno v:
Seminars in oncology. 24(1)
Hematopoietic growth factors (GFs) are administered to patients who have acute myeloid leukemia (AML) in order to overcome two limitations of chemotherapy: (I) myelotoxicity, and (2) the chemoresistance of minimal residual disease. GFs have been used
Autor:
T. Büchner, P. Koch, G. Maschmeier, H. J. Pielken, Achim Heinecke, J. van de Loo, Wolfgang Hiddemann, D. Urbanitz, F. Wendt
Publikováno v:
Oncology Research and Treatment. 8:157-159
102 patients with AML (leukemia after preleukemia, 2nd neoplasia included) were treated for remission induction by a modified TAD regimen in Munster; 55 patients (54%) achieved a complete remission (CR). For CR maintenance 40 patients were eligible f
Autor:
Górecki, Krzysztof1 krzysztof.gorecki@up.poznan.pl
Publikováno v:
Polish Journal of Entomology. 2022, Vol. 91 Issue 4, p149-160. 12p.
Autor:
D, Urbanitz, H J, Pielken, P, Koch, T, Büchner, W, Hiddemann, A, Heinecke, F, Wendt, G, Maschmeier, J, van de Loo
Publikováno v:
Onkologie. 8(3)
102 patients with AML (leukemia after preleukemia, 2nd neoplasia included) were treated for remission induction by a modified TAD regimen in Munster; 55 patients (54%) achieved a complete remission (CR). For CR maintenance 40 patients were eligible f
Autor:
Achim Heinecke, Th. Büchner, G. Maschmeier, W.-D. Ludwig, Peter Koch, D. Urbanitz, J. van de Loo, H. J. Pielken
Publikováno v:
Acute Leukemias ISBN: 9783540165569
Between July 1, 1981, and July 1, 1985, 167 patients with acute myelogeneous leukemia (AML) were treated with one or, if necessary, two courses of a modified TAD regimen (TAD9) for induction. 96 patients (58%) achieved a complete remission (CR); 62 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c22b2428a97759bb4c327bb27a22b958
https://doi.org/10.1007/978-3-642-71213-5_11
https://doi.org/10.1007/978-3-642-71213-5_11
Autor:
D, Urbanitz, T, Büchner, H, Pielken, P, Koch, W D, Ludwig, G, Maschmeier, A, Heinecke, J, van de Loo
Publikováno v:
Haematology and blood transfusion. 30
Between July 1, 1981, and July 1, 1985, 167 patients with acute myelogeneous leukemia (AML) were treated with one or, if necessary, two courses of a modified TAD regimen (TAD9) for induction. 96 patients (58%) achieved a complete remission (CR); 62 a
Autor:
P. Meyer, H. Huber, W. Havers, W. Brandeis, I. Doxiadis, H.J. Kolb, H.H. Gerhartz, H. Gadner, P. Preusser, D. Niederwieser, U. Jehn, M. Freund, J. van de Loo, C. Abbrederis, W. Wilmanns, C.G. Schmidt, H. Denz, P. Koch, A.D. Ho, G. Ehninger, E. Seither, D. Urbanitz, I. Mjaaland, U.W. Schaefer, H.J. Richter, H. Grosse-Wilde, R. Flener, T. Büchner, B. Löwenberg, R. Zittoun, H. Jürgens, S. Öhl, H.-J. Spaar, P. Ostendorf, U. Göbel, J. Wiegele, D. Beelen, C. Huber, L. Balleisen, R. Eisert, W. Hiddemann, H. Bodenstein, J. Mittermüller, W. Achterrath, G. Maschmeier, H.K. Mahmoud, F. Wendt, G. Gastl, H.-J. Pielken, J. Troppmair, H. Poliwoda, A. Heinecke
Publikováno v:
Oncology Research and Treatment. 8:140-140
Autor:
Amarapurkar, Anjali1 (AUTHOR), Kale, Kshitija1 (AUTHOR), Naik, Leena1 (AUTHOR), Shukla, Akash2 (AUTHOR)
Publikováno v:
Indian Journal of Pathology & Microbiology. 2021 Supplement, Vol. 64, p69-72. 4p.
Autor:
Yasugi, Kengo1 (AUTHOR), Haruma, Ken1 (AUTHOR), Kawanaka, Miwa1 (AUTHOR), Suehiro, Mitsuhiko1 (AUTHOR), Nakamura, Jun1 (AUTHOR), Urata, Noriyo1 (AUTHOR), Tanikawa, Tomohiro1 (AUTHOR), Oka, Takahito1 (AUTHOR), Monobe, Yasumasa2 (AUTHOR), Fujita, Takuya3 (AUTHOR), Kawamoto, Hirofumi1 (AUTHOR)
Publikováno v:
Case Reports in Gastroenterology. 2021, Vol. 15 Issue 1, p202-209. 8p.
Autor:
Kaplan DE; Department of Medicine, Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Gastroenterology Section, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA USA., Ripoll C; Internal Medicine IV, Jena University Hospital, Friedrich Schiller University, Jena, Germany., Thiele M; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Fortune BE; Department of Gastroenterology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA., Simonetto DA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Garcia-Tsao G; Yale University, New Haven, USA; VA-CT Healthcare System, West Haven, CT, USA., Bosch J; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS) and CIBERehd, University of Barcelona, Spain.
Publikováno v:
Hepatology (Baltimore, Md.) [Hepatology] 2024 May 01; Vol. 79 (5), pp. 1180-1211. Date of Electronic Publication: 2023 Oct 23.